Bio Impact Capital LLC Ultragenyx Pharmaceutical Inc. Transaction History
Bio Impact Capital LLC
- $669 Million
- Q4 2024
A detailed history of Bio Impact Capital LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bio Impact Capital LLC holds 391,018 shares of RARE stock, worth $15.5 Million. This represents 2.46% of its overall portfolio holdings.
Number of Shares
391,018
Previous 329,733
18.59%
Holding current value
$15.5 Million
Previous $18.3 Million
10.19%
% of portfolio
2.46%
Previous 2.86%
Shares
4 transactions
Others Institutions Holding RARE
# of Institutions
345Shares Held
86.7MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$398 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$222 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$171 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$108 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$99.7 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.78B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...